Company Overview of Clingenix, Inc.
Clingenix, Inc. is a biotechnology company focusing on development and clinical validation of novel molecular diagnostics such as molecular screens for insulin resistance (IR). The company was founded in 1998 and is based in Sunnyvale, California with additional offices in China and Taiwan.
1308 Borregas Avenue
Sunnyvale, CA 94089
Founded in 1998
Key Executives for Clingenix, Inc.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
Sponsored Financial Commentaries
To contact Clingenix, Inc., please visit www.clingenix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.